Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

ASPR’s Portfolio of COVID-19 Medical Countermeasures

Products Made Available as Licensed Products or under FDA's Emergency Use Authorization

Therapeutic Products

casirivimab/imdevimab. Regeneron.Bamlanivimab by Eli Lilly1. Veklury (Remdesivir) (Gilead Sciences, Inc.)Convalescent plasma (Multiple Contracts)

Diagnostic Tests 

Point-of-Care COVID019 Cue Health Monitoring System & Mobile App (Cue Health Inc)Accula SARS-CoV-2 Test (Mesa Biotech)Xpert Xpress SARS-CoV-2 Test (Cepheid)Panther Fusion SARS-CoV-2  Assay (Hologic)NxTag CoV Extended Panel Assay (Luminex) Aries SARS-CoV-2 Test (Luminex)8.    LIASON SARS-CoV-2 S1/S2 IgG (DiaSorin Inc.)QIAstat-Dx RPS2  (Qiagen) 1. Cepheid – Xpert Xpress SARS-COV-2/Flu/RSV test 2. GenMark Diagnostics, Inc. – ePlex Respiratory Pathogen v2 Panel Hologic, Inc. – Aptima® SARS-CoV-2-assay Qiagen, LLC – QIAstat-Dx Respiratory SARS-CoV-2 Panel Siemens Healthineers – ADVIA Centaur® SARS-CoV-2 Total (CoV2T) assay 6. Siemens Healthineers – Atelica® IM SARS-CoV-2 Total (COV2T) assay Vela Diagnostics USA, Inc. – ViroKey™ SARS-CoV-2RT-PCR Test 

To learn about the products that are currently under development, see ASPR/BARDA's COVID-19 medical countermeasure portfolio.

  • This page last reviewed: January 28, 2021